Drug Report History #5445
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v7-FR | Version v1-EN |
|---|---|---|
| Language | French (Updated) | English |
| Date Updated | 2017-10-11 (Updated) | 2017-04-04 |
| Drug Identification Number | 02230837 | 02230837 |
| Brand name | XYLAC | XYLAC |
| Common or Proper name | XYLAC 5mg TABS 100 | XYLAC 5mg TABS 100 |
| Company Name | PENDOPHARM DIVISION OF DE PHARMASCIENCE INC | PENDOPHARM DIVISION OF DE PHARMASCIENCE INC |
| Ingredients | LOXAPINE | LOXAPINE |
| Strength(s) | 5MG | 5MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL | ORAL |
| Packaging size | 100 Tabs | 100 Tabs |
| ATC code | N05AH | N05AH |
| ATC description | ANTIPSYCHOTICS | ANTIPSYCHOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-06-26 | 2017-06-26 |
| Actual start date | 2017-06-26 (Updated) | |
| Estimated end date | Unknown | Unknown |
| Actual end date | ||
| Shortage status | Actual shortage (Updated) | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | other strengths available | other strengths available |
| Health Canada comments |